AOA 2025: LNZ100 clinical trial insights from Dr Marc Bloomenstein

Published on July 11, 2025
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Continue reading on website
Other news

Retinal Sensitivity Loss Extends Past Lesion Borders in GA

July 11, 2025
The reduced sensitivity around GA lesions noted in this study appeared to be a combination of global macular sensitivity loss from AMD and additional losses specifically associated with GA, closely tied to the distance from the GA border. These images from the study show the overlaying of retinal sensitivity measurements on fundus autofluorescence images and calculation of distances between test p

Need for a national glaucoma pathway emphasised during Westminster Hall debate

July 11, 2025
Shockat Adam MP aimed to raise awareness of glaucoma and called for a national framework for monitoring and treatment during the debate in Parliament